We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$120M
AUM Growth
+$15.6M
Cap. Flow
+$15.6M
Cap. Flow %
13.04%
Top 10 Hldgs %
46.75%
Holding
154
New
30
Increased
62
Reduced
44
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 15.26%
2 Technology 12.31%
3 Communication Services 5.77%
4 Industrials 3.81%
5 Energy 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$957K 0.8%
30,108
+20,430
+211% +$666K
IBB icon
27
iShares Biotechnology ETF
IBB
$9.34B
$936K 0.78%
7,614
+228
+3% +$27.3K
FENY icon
28
Fidelity MSCI Energy Index ETF
FENY
$2.01B
$845K 0.71%
39,183
+15,534
+66% +$355K
TRN icon
29
Trinity Industries
TRN
$2.49B
$845K 0.71%
44,412
+5,120
+13% +$115K
GE icon
30
GE Aerospace
GE
$374B
$844K 0.7%
6,633
-235
-3% -$30.5K
TNA icon
31
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.3B
$814K 0.68%
18,220
-610
-3% -$27.5K
BIIB icon
32
Biogen
BIIB
$30B
$799K 0.67%
+1,980
New +$795K
V icon
33
Visa
V
$684B
$784K 0.65%
11,682
+53
+0.5% +$3.59K
UAA icon
34
Under Armour
UAA
$2.84B
$775K 0.65%
18,720
+4,828
+35% +$194K
JPM icon
35
JPMorgan Chase
JPM
$935B
$771K 0.64%
11,387
+4,904
+76% +$320K
NMZ icon
36
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$730K 0.61%
55,931
+9,785
+21% +$132K
NFLX icon
37
Netflix
NFLX
$299B
$719K 0.6%
76,650
+17,850
+30% +$149K
BMY icon
38
Bristol-Myers Squibb
BMY
$133B
$695K 0.58%
10,455
+5,452
+109% +$359K
PCN
39
PIMCO Corporate & Income Strategy Fund
PCN
$870M
$678K 0.57%
47,801
-3,804
-7% -$57.3K
AGG icon
40
iShares Core US Aggregate Bond ETF
AGG
$137B
$672K 0.56%
6,180
+255
+4% +$28K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.1T
$643K 0.54%
4,730
+935
+25% +$133K
FIDU icon
42
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
$616K 0.51%
21,903
+6,033
+38% +$175K
BIB icon
43
ProShares Ultra NASDAQ Biotechnology
BIB
$81.2M
$604K 0.5%
6,685
+645
+11% +$55.5K
IXN icon
44
iShares Global Tech ETF
IXN
$8.32B
$576K 0.48%
36,144
+180
+0.5% +$2.98K
EQNR icon
45
Equinor
EQNR
$97.7B
$567K 0.47%
31,703
+9,090
+40% +$176K
SLYV icon
46
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$567K 0.47%
+10,696
New +$573K
MCK icon
47
McKesson
MCK
$100B
$554K 0.46%
2,466
-29
-1% -$6.71K
SCZ icon
48
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$537K 0.45%
10,527
+583
+6% +$30.4K
BP icon
49
BP
BP
$116B
$531K 0.44%
+15,808
New +$553K
GT icon
50
Goodyear
GT
$2B
$531K 0.44%
17,620
+812
+5% +$24.1K

Similar funds

Traynor Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Traynor Capital Management held 154 positions worth $120M, up 15% from $104M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Traynor Capital Management deployed $15.6M of net new capital in Q2 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Biogen: 1,980 shares worth $799K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $398K trimmed.

  • Traynor Capital Management's largest Q2 2015 buy was Biogen: 1,980 shares worth $799K.
  • Traynor Capital Management added most to Novo Nordisk in Q2 2015, an estimated $2.65M increase.
  • Traynor Capital Management's biggest Q2 2015 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $398K.
  • Traynor Capital Management fully exited Eli Lilly in Q2 2015, selling an estimated $605K.
  • Traynor Capital Management's ten largest holdings make up 47% of its $120M portfolio in Q2 2015.
  • Traynor Capital Management opened 30 new positions and closed 13 in Q2 2015.
  • Traynor Capital Management's portfolio value rose 15% quarter-over-quarter to $120M.

Based on Traynor Capital Management's 13F filing for Q2 2015, filed 23 Feb 2016.